RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Dec 17, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-12-14

Reporting Person: Nolan Lisa (Chief Business Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Direct
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$13.50	2025-04-06	Common Stock (50000)		Direct

Footnotes

F1: 30,000 shares of restricted stock granted on April 6, 2015. A total of 25% of the stock will vest one year from the grant date, and the remaining 75% shall vest in equal quarterly increments of 6.25% of the initial option grant over the following three year period.

F2: Options granted on April 6, 2015 to purchase an aggregate of 50,000 shares of common stock. A total of 25% of the options will vest one year from the grant date, and the remaining 75% shall vest in equal quarterly increments of 6.25% of the initial option grant over the following three year period.